Page last updated: 2024-08-23

etoposide and a 443654

etoposide has been researched along with a 443654 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blalock, WL; Cappellini, A; Chiarini, F; Cocco, L; Falà, F; Martelli, AM; Martinelli, G; McCubrey, JA; Tafuri, A; Tazzari, PL	1

Other Studies

1 other study(ies) available for etoposide and a 443654

Article	Year
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-cell acute lymphoblastic leukemia. Molecular pharmacology, 2008, Volume: 74, Issue:3 Topics: Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; Etoposide; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indazoles; Indoles; Leukemia-Lymphoma, Adult T-Cell; Phosphorylation; Phosphoserine; Phosphothreonine; Proto-Oncogene Proteins c-akt	2008

Article

Year

Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-cell acute lymphoblastic leukemia.

Molecular pharmacology, 2008, Volume: 74, Issue:3

Topics: Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; Etoposide; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indazoles; Indoles; Leukemia-Lymphoma, Adult T-Cell; Phosphorylation; Phosphoserine; Phosphothreonine; Proto-Oncogene Proteins c-akt

2008